Gelteq Ltd — Investor Relations & Filings
Filings indexed
68
across all filing types
Latest filing
2026-05-26
Regulatory Filings
Country
US
United States of America
Listing
US
GELS
Gelteq Ltd. is a biotechnology company that specializes in the formulation, development, and manufacturing of a patented, ingestible gel-based oral delivery system. Its proprietary technology platform is designed to improve the delivery of drugs and nutrients for both humans and animals. The gel matrix can integrate water-soluble and lipid-soluble components simultaneously, aiming to enhance absorption, mask taste, and reduce choking risks associated with traditional oral dosage forms. The company collaborates with partners in the pharmaceutical, over-the-counter (OTC), nutraceutical, and nutrition sectors to formulate and commercialize products, offering white-label solutions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-26 | English | |
| 6-K - Gelteq Ltd (0001920092) (Filer) | 2026-03-24 | English | |
| 3 - Gelteq Ltd (0001920092) (Issuer) | 2026-03-19 | English | |
| 3 - Gelteq Ltd (0001920092) (Issuer) | 2026-03-19 | English | |
| 3 - Gelteq Ltd (0001920092) (Issuer) | 2026-03-19 | English | |
| 3 - Gelteq Ltd (0001920092) (Issuer) | 2026-03-19 | English |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 47072219 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-26 | English | ||
| 33031851 | 6-K - Gelteq Ltd (0001920092) (Filer) | 2026-03-24 | English | ||
| 32981145 | 3 - Gelteq Ltd (0001920092) (Issuer) | 2026-03-19 | English | ||
| 32981142 | 3 - Gelteq Ltd (0001920092) (Issuer) | 2026-03-19 | English | ||
| 32980816 | 3 - Gelteq Ltd (0001920092) (Issuer) | 2026-03-19 | English | ||
| 32980809 | 3 - Gelteq Ltd (0001920092) (Issuer) | 2026-03-19 | English | ||
|
2025
9 filings
| |||||
| 13581780 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-09 | English | ||
| 13581781 | ANNUAL REPORT | 2025-11-14 | English | ||
| 13581783 | NOTIFICATION OF LATE FILING | 2025-11-03 | English | ||
| 13581782 | Regulatory Filings 2025 | 2025-09-02 | English | ||
| 13581784 | PROSPECTUS | 2025-08-29 | English | ||
| 13581785 | Regulatory Filings 2025 | 2025-08-28 | English | ||
| 13581786 | REGISTRATION STATEMENT | 2025-07-25 | English | ||
| 13581787 | Regulatory Filings 2025 | 2025-07-08 | English | ||
| 13581788 | REGISTRATION STATEMENT | 2025-07-01 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AVADEL PHARMACEUTICALS PLC
Biopharmaceutical company developing therapies for sleep di…
|
AVDL | US | Manufacturing |
|
Avagenesis Corp.
Develops automated technology for isolating and enriching r…
|
VVA | CA | Manufacturing |
|
Avalon GloboCare Corp.
Develops cell-based immunotherapies and provides precision …
|
ALBT | US | Manufacturing |
|
AVECHO BIOTECHNOLOGY LIMITED
Develops human and animal health products using TPM® drug d…
|
AVE | AU | Manufacturing |
|
Avicanna Inc.
Commercial-stage international biopharma focused on evidenc…
|
AVCN | CA | Manufacturing |
|
Avidity Biosciences, Inc.
Develops a class of RNA therapeutics called Antibody Oligon…
|
RNA | US | Manufacturing |
|
Avivagen Inc.
Developed natural health products and feed additives; filed…
|
VIV | CA | Manufacturing |
|
Awakn Life Sciences Corp. (1169082 BC Ltd.)
Clinical-stage biotech developing novel therapeutics, inclu…
|
AWKN | CA | Manufacturing |
|
Axcan Pharma Inc.
Specialty pharmaceutical company focused on prescription th…
|
AXCA | CA | Manufacturing |
|
Axogen, Inc.
Develops and commercializes surgical solutions for peripher…
|
AXGN | US | Manufacturing |
Gelteq Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35105/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35105 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35105 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35105 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35105}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Gelteq Ltd (id: 35105)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.